Warner Chilcott Sues Mylan To Block Generic Lo Loestrin

Law360, New York (November 1, 2013, 1:52 PM EDT) -- Warner Chilcott Co. LLC launched suit in New Jersey federal court Wednesday alleging Mylan Inc. has infringed its patent for oral contraceptive Lo Loestrin Fe by seeking federal approval to launch a generic version of the birth control before Warner’s patent expires.

Warner Chilcott claims Mylan subsidiary Famy Care Ltd. has filed an abbreviated new drug application with the U.S. Food and Drug Administration seeking approval to manufacture and market a generic version of Lo Loestrin Fe before Warner Chilcott’s patent covering the contraceptive’s dosing regimen...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.